Imunon, Inc. — Director's Dealing 2011

Jan 19, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-01-14

Reporting Person: Tardugno Michael H (CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-14	Series A Redeemable Convertible Preferred Stock	$2.4	P	41	Acquired	2013-01-14	Celsion Corporation Common Stock (17083.33)	Direct
2011-01-14	Warrants to Purchase Common Stock	$3.25	P	17083.3306	Acquired	2016-07-14	Celsion Corporation Common Stock (17083.3306)	Direct

Footnotes

F1: Represents the date which the NASDAQ Stock Market LLC approved the participation of insiders in the public offering in which the securities were purchased by the reporting person and the date on which the reporting person became irrevocably committed to purchase the securities covered by this report.

F2: The securities were purchased in a public offering pursuant to Celsion Corporation's Registration Statement on Form S-3 (File No. 333-158402) that was declared effective on April 17, 2009 (the "Registration Statement") on the terms and conditions set forth in the prospectus supplements to the Registration Statement dated January 12, 2011 and January 13, 2011.

F3: Represents the conversion price per share of the Series A Convertible Preferred Stock.

F4: Represents the exercise price of the warrants per whole share of common stock.

F5: Each unit of a warrant to purchase 416.6666 shares of common stock was purchased for $0.125 per unit, which represents the value allocated to the unit in accordance with the NASDAQ Stock Market Rules.

F6: Represents the at-the-market purchase price per share of Series A Convertible Preferred Stock allocated to each such share in accordance with the NASDAQ Stock Market Rules.